|
Johnson & Johnson COVID-19 vaccine named one of Time's Best Inventions of 2021
|
12 November 2021 |
|
17 million doses of Johnson & Johnson COVID-19 vaccine to be donated to African Union countries
|
19 October 2021 |
|
Positive new data for Johnson & Johnson single-shot COVID-19 vaccine on activity against Delta variant and long-lasting durability of response
|
07 July 2021 |
|
Johnson & Johnson statement on COVID-19 vaccine
|
14 April 2021 |
|
Johnson & Johnson announces advance purchase agreement with the African Vaccine Acquisition Trust
|
29 March 2021 |
|
Johnson & Johnson announces aingle-ahot Janssen COVID-19 vaccine candidate met primary endpoints in interim analysis of its Phase 3 ENSEMBLE trial
|
08 March 2021 |
|
Johnson & Johnson Announces Submission to World Health Organization for Emergency Use Listing of investigational single-shot Janssen COVID-19 vaccine candidate
|
22 February 2021 |
|
Johnson & Johnson announces submission of application to the U.S. FDA for Emergency Use Authorization of its investigational single-shot Janssen COVID-19 vaccine candidate
|
05 February 2021 |
|
Johnson & Johnson announces initiation of rolling submission for its single-dose Janssen COVID-19 vaccine candidate with the European Medicines Agency
|
04 December 2020 |
|
Johnson & Johnson initiates second global Phase 3 clinical trial of its Janssen COVID-19 vaccine candidate
|
26 November 2020 |
|
Johnson & Johnson prepares to resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 vaccine candidate in the U.S.
|
26 October 2020 |
|
Johnson & Johnson announces European Commission approval of agreement to supply 200 million doses of Janssen's COVID-19 vaccine candidate
|
08 October 2020 |
|
Johnson & Johnson initiates pivotal global Phase 3 clinical trial of Janssen's COVID-19 vaccine candidate
|
28 September 2020 |
|
Johnson & Johnson announces that Janssen's COVID-19 investigational vaccine candidate prevents severe clinical disease in pre-clinical studies
|
07 September 2020 |
|
Johnson & Johnson announces agreement with U.S. government for 100 million doses of investigational COVID-19 vaccine
|
13 August 2020 |
|
Single dose of Johnson & Johnson COVID-19 vaccine candidate demonstrates robust protection in pre-clinical studies
|
30 July 2020 |
|
Johnson & Johnson announces acceleration of its COVID-19 vaccine candidate; Phase 1/2a clinical trial to begin in second half of July
|
10 June 2020 |
|
Johnson & Johnson announces collaboration to expand manufacturing capabilities for its COVID-19 vaccine candidate
|
18 May 2020 |
|
Johnson & Johnson announces a lead vaccine candidate for COVID-19
|
07 April 2020 |
|
Johnson & Johnson announces collaboration with U.S. Department of Health and Human Services to fight influenza
|
18 September 2017 |